What Are the Symptoms of Cystic Fibrosis?
Symptoms of lung disease can start in infancy, especially following upper respiratory viral infections. People with CF may experience a small but progressive (worsening) loss in lung function with every passing year, leading to increased symptoms as you age. Some children remain relatively healthy throughout childhood and only start to experience a decline in their lung function when they are teenagers.
There is a wide range of severity in CF symptoms. Even within the same family, siblings can have different disease severity. Symptoms of CF can be classified into two main categories: respiratory and digestive.
The most common symptoms of CF respiratory tract disease are:
- Chronic coughing (dry or coughing up mucus)
- Recurring chest colds
- Wheezing or shortness of breath
- Frequent sinus infections
Digestive symptoms may include greasy, foul-smelling bowel movements, severe constipation or intestinal blockage and the inability to gain weight while being constantly hungry. Depending on what organs are affected, other symptoms may include jaundice or yellowing of the skin and eyes, muscle and joint pain, pancreatitis, salty skin, slow growth and shorter height.
How Cystic Fibrosis Is Diagnosed
- Newborn screening. In the last decade, newborn screening has become standard in all 50 U.S. states and the District of Columbia. The newborn screen shows infants who have a high level of an enzyme called immunoreactive trypsin (IRT) in their blood. This occurs when there is injury to the pancreas. The test is repeated if it is abnormal. Some states also combine this with testing for the most common gene mutation called deltaF508. The next step is to refer the infant for further testing as there are many “false-positive” tests. This entails taking a blood sample to check whether the infant has two genes that cause CF and/or performing a sweat test. Newborn screening protocols vary from state to state, so talk to your healthcare provider about what steps your state follows if the test result is inconclusive.
- Newborn screening helps avoid delayed diagnosis and allows for early treatment intervention for better management of the disease.
- Genetic testing. More than 2,000 different mutations of the CF gene have been identified. Most of them are quite rare, but a few are common, like the deltaF508 mutation that is found in at least 70% of individuals with CF. Genetic testing can determine the exact mutation in most cases. For couples who want to have children, genetic testing is also important as more than 10 million people living in the United States are carriers of a CF gene. For every pregnancy, there is a one-in-four chance that the child will have CF when both parents are carriers.
- Sweat test. Sweat is collected from a small area on the child’s forearm, and the chloride levels are measured. Children with CF have high levels of chloride in their sweat because a lack of CFTR prevents the salt on the skin from being reabsorbed back into the sweat glands.
- Measuring nasal lining, also called nasal potential difference (NPD). Another way to confirm the diagnosis is to run a small electrical current across the nasal lining (epithelium). Different solutions are applied to the nasal lining and the electrical current is measured. People with CF respond very differently than those without CF to this test, and it may help confirm a diagnosis.
Reviewed and approved by the American Lung Association Scientific and Medical Editorial Review Panel.
Page last updated: October 30, 2024